132326-74-0

H2-D b restricted epitopes VSV  Nucleoprotein (52-59) Chemical Structure
132326-74-0

Chemical Structure

H2-D b restricted epitopes VSV Nucleoprotein (52-59)

  • CAS No.: 132326-74-0
  • Formula:C44H66N12O12
  • Molecular Weight:955.07

InChIKey: JJIXGGRYEUBGKS-HLRRNAAZSA-N

SMILES: O=C(N[C@@H](CCC(N)=O)C(NCC(N[C@H](C(O)=O)CC(C)C)=O)=O)[C@@H](NC([C@H](C(C)C)NC([C@@H](NC(CNC([C@@H](N)CCCNC(N)=N)=O)=O)CC(C=C1)=CC=C1O)=O)=O)CC(C=C2)=CC=C2O

Biological Activity: H2-D b restricted epitopes VSV Nucleoprotein (52-59) is a 9-mer peptide derived from the nucleoprotein of Vesicular Stomatitis Virus (VSV). H2-D b restricted epitopes VSV Nucleoprotein (52-59) binds to MHC class I molecules and presents itself to CD8+ T cells, thereby activating cytotoxic T lymphocytes (CTLs), which can recognize and kill cells expressing the corresponding antigen. H2-D b restricted epitopes VSV Nucleoprotein (52-59) can be used in the development of CTL vaccines against Ebola virus[1].

Cat. No. Product Name Purity Description Pricing
HY-P3070
H2-D b restricted epitopes VSV Nucleoprotein (52-59) H2-D b restricted epitopes VSV Nucleoprotein (52-59) is a 9-mer peptide derived from the nucleoprotein of Vesicular Stomatitis Virus (VSV). H2-D b restricted epitopes VSV Nucleoprotein (52-59) binds to MHC class I molecules and presents itself to CD8+ T cells, thereby activating cytotoxic T lymphocytes (CTLs), which can recognize and kill cells expressing the corresponding antigen. H2-D b restricted epitopes VSV Nucleoprotein (52-59) can be used in the development of CTL vaccines against Ebola virus.
Pricing 
Expand Hide
loading...
/
  • /
loading...
Size Price
Stock Quantity Availability Operate
/
In-stock
(Estimated to ship on )
(Estimated to ship TODAY)
Estimated to ship on
(Estimated to ship TODAY)

Amount:

USD 0.00

This product is a controlled substance and not for sale in your territory.

This product is not for sale in your territory.

Pricing 
Expand Hide
References